NovaBridge Biosciences
USD1.83
+0.04 (+2.23%)
CEO
Srishti Gupta
IPO Date
2020-01-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.76
Prev. Close
$1.79
Day Low
$1.74
Day High
$1.84
52W Low
$1.46
52W High
$6.79
Market Cap
$0.21B
Volume
0.27M
| 254,780 |
| $1.93 |
| 8 Jul 2026 | Gupta Srishti | director, officer: Chief Executive Officer | A-Award | Acquired | 3,000,000 | $2.01 |
| 8 Jul 2026 | Gupta Srishti | — | Disposed | 0 | $0.00 |
| 7 Jul 2026 | Xu Cong Claire | SVP, Clinical Development | M-Exempt | Acquired | 12,432 | $0.00 |
| 7 Jul 2026 | Xu Cong Claire | SVP, Clinical Development | S-Sale | Disposed | 4,485 | $0.89 |
| 7 Jul 2026 | Xu Cong Claire | SVP, Clinical Development | M-Exempt | Disposed | 5,405 | $0.00 |
| 30 Jun 2026 | Fu Wei | director | A-Award | Acquired | 725,140 | $2.45 |
| 30 Jun 2026 | Fu Wei | director | A-Award | Acquired | 1,087,720 | $2.45 |
| 30 Jun 2026 | Fu Wei | director | A-Award | Acquired | 1,010,100 | $0.00 |